Apomorphine (APO-go & Dacepton)

BNF:: 4.9.1
Status:: Amber
Decision Date:: December 2019

Comments

See shared care guideline for Parkinson's disease

Amber Drug Classifications

1: Requiring specialist assessment to enable patient selection and initiation of treatment